Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS

[1]  H. Chen,et al.  The β-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages , 2014, Nature Communications.

[2]  J. Köhl,et al.  Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE. , 2014, The Journal of clinical investigation.

[3]  A. Cuadrado,et al.  Transcription Factors NRF2 and NF-κB Are Coordinated Effectors of the Rho Family, GTP-binding Protein RAC1 during Inflammation* , 2014, The Journal of Biological Chemistry.

[4]  M. Varrin-doyer,et al.  Dimethyl Fumarate Utilizes Nrf2-Independent and Nrf2-Dependent Pathways For Immune Modulation (S53.006) , 2014 .

[5]  A. Uccelli,et al.  Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis , 2014, Immunology.

[6]  M. Tomita,et al.  Erratum: Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells , 2014, Nature.

[7]  Huidong Shi,et al.  Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. , 2014, Immunity.

[8]  M. Tomita,et al.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells , 2013, Nature.

[9]  A. Rudensky,et al.  Metabolites produced by commensal bacteria promote peripheral regulatory T cell generation , 2013, Nature.

[10]  A. Takakura,et al.  The role of HCA2 (GPR109A) in regulating macrophage function , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  T. Suuronen,et al.  Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders. , 2013, Cellular signalling.

[12]  R. Gold,et al.  Dimethyl Fumarate for Treatment of Multiple Sclerosis: Mechanism of Action, Effectiveness, and Side Effects , 2013, Current Neurology and Neuroscience Reports.

[13]  D. Centonze,et al.  Interleukin-1β Alters Glutamate Transmission at Purkinje Cell Synapses in a Mouse Model of Multiple Sclerosis , 2013, The Journal of Neuroscience.

[14]  M. Ishii,et al.  Layer V cortical neurons require microglial support for survival during postnatal development , 2013, Nature Neuroscience.

[15]  O. Garaschuk,et al.  Microglial calcium signaling in the adult, aged and diseased brain. , 2013, Cell calcium.

[16]  David H. Miller,et al.  Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis. , 2012, The New England journal of medicine.

[17]  D. Arnold,et al.  Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. , 2012, The New England journal of medicine.

[18]  K. Krieglstein,et al.  TGFβ signalling plays an important role in IL4-induced alternative activation of microglia , 2012, Journal of Neuroinflammation.

[19]  S. Offermanns,et al.  G protein-coupled receptors for energy metabolites as new therapeutic targets , 2012, Nature Reviews Drug Discovery.

[20]  Yuhong Yang,et al.  Dimethyl Fumarate Inhibits Dendritic Cell Maturation via Nuclear Factor κB (NF-κB) and Extracellular Signal-regulated Kinase 1 and 2 (ERK1/2) and Mitogen Stress-activated Kinase 1 (MSK1) Signaling* , 2012, The Journal of Biological Chemistry.

[21]  K. Rhodes,et al.  Fumarates Promote Cytoprotection of Central Nervous System Cells against Oxidative Stress via the Nuclear Factor (Erythroid-Derived 2)-Like 2 Pathway , 2012, Journal of Pharmacology and Experimental Therapeutics.

[22]  D. Greaves,et al.  Anti-Inflammatory Effects of Nicotinic Acid in Human Monocytes Are Mediated by GPR109A Dependent Mechanisms , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[23]  A. Menssen,et al.  The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop , 2011, Proceedings of the National Academy of Sciences.

[24]  Jianqing Ding,et al.  CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's disease , 2011, Journal of Neuroinflammation.

[25]  D. Centonze,et al.  Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis , 2011, Brain, Behavior, and Immunity.

[26]  W. Brück,et al.  Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. , 2011, Brain : a journal of neurology.

[27]  S. Offermanns,et al.  Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells. , 2011, The Journal of clinical investigation.

[28]  F. Greten,et al.  IκBβ is an essential co-activator for LPS-induced IL-1β transcription in vivo , 2010, The Journal of Experimental Medicine.

[29]  D. Centonze,et al.  Abnormal activity of the Na/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis , 2010, Brain, Behavior, and Immunity.

[30]  S. Tunaru,et al.  Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice. , 2010, The Journal of clinical investigation.

[31]  U. Mrowietz,et al.  Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1β, TNF-α and IL-6 in an in-vitro model of brain inflammation , 2010, Journal of Neuroinflammation.

[32]  Zhenggang Yang,et al.  Macrophage α1 AMP-activated Protein Kinase (α1AMPK) Antagonizes Fatty Acid-induced Inflammation through SIRT1* , 2010, The Journal of Biological Chemistry.

[33]  T. Pabst,et al.  PU.1 is regulated by NF-κB through a novel binding site in a 17 kb upstream enhancer element , 2010, Oncogene.

[34]  R. Bolli,et al.  Gene Transfer of Inducible Nitric Oxide Synthase Affords Cardioprotection by Upregulating Heme Oxygenase-1 Via a Nuclear Factor-&kgr;B–Dependent Pathway , 2009, Circulation.

[35]  I. Merfort,et al.  Dimethylfumarate inhibits NF-{kappa}B function at multiple levels to limit airway smooth muscle cell cytokine secretion. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[36]  W. Seaman,et al.  A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia , 2009, Journal of neurochemistry.

[37]  F. Gage,et al.  A Nurr1/CoREST Pathway in Microglia and Astrocytes Protects Dopaminergic Neurons from Inflammation-Induced Death , 2009, Cell.

[38]  J. Nabekura,et al.  Resting Microglia Directly Monitor the Functional State of Synapses In Vivo and Determine the Fate of Ischemic Terminals , 2009, The Journal of Neuroscience.

[39]  D. Centonze,et al.  Inflammation Triggers Synaptic Alteration and Degeneration in Experimental Autoimmune Encephalomyelitis , 2009, The Journal of Neuroscience.

[40]  J. Reagan,et al.  The psoriasis drug monomethylfumarate is a potent nicotinic acid receptor agonist. , 2008, Biochemical and biophysical research communications.

[41]  E. Hoffman,et al.  Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. , 2008, Developmental cell.

[42]  Shyam Biswal,et al.  Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. , 2007, Annual review of pharmacology and toxicology.

[43]  Steffen Jung,et al.  Control of microglial neurotoxicity by the fractalkine receptor , 2006, Nature Neuroscience.

[44]  R. Gold,et al.  Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration , 2006, Clinical and experimental immunology.

[45]  Z. Benyó,et al.  GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing. , 2005, The Journal of clinical investigation.

[46]  G. Mancardi,et al.  Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. , 2005, Blood.

[47]  A. Wierinckx,et al.  Detoxication enzyme inducers modify cytokine production in rat mixed glial cells , 2005, Journal of Neuroimmunology.

[48]  A. Means,et al.  The Ca2+/Calmodulin-dependent Protein Kinase Kinases Are AMP-activated Protein Kinase Kinases* , 2005, Journal of Biological Chemistry.

[49]  D. Connolly,et al.  (d)-β-Hydroxybutyrate Inhibits Adipocyte Lipolysis via the Nicotinic Acid Receptor PUMA-G* , 2005, Journal of Biological Chemistry.

[50]  H. Neumann,et al.  Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2 , 2005, The Journal of experimental medicine.

[51]  S. Imai,et al.  The NAD Biosynthesis Pathway Mediated by Nicotinamide Phosphoribosyltransferase Regulates Sir2 Activity in Mammalian Cells* , 2004, Journal of Biological Chemistry.

[52]  M. Mayo,et al.  Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase , 2004, The EMBO journal.

[53]  P. De Baetselier,et al.  Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages , 2002, Journal of leukocyte biology.

[54]  B. Bresnihan,et al.  Activation of Nuclear Orphan Receptor NURR1 Transcription by NF-κB and Cyclic Adenosine 5′-Monophosphate Response Element-Binding Protein in Rheumatoid Arthritis Synovial Tissue1 , 2002, The Journal of Immunology.

[55]  A. Edelman,et al.  Components of a Calmodulin-dependent Protein Kinase Cascade , 1998, The Journal of Biological Chemistry.

[56]  C. Usai,et al.  Expression of CD38 Increases Intracellular Calcium Concentration and Reduces Doubling Time in HeLa and 3T3 Cells* , 1998, The Journal of Biological Chemistry.

[57]  N. Abraham,et al.  Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[58]  P. Ricciardi-Castagnoli,et al.  Monokine production by microglial cell clones , 1989, European journal of immunology.

[59]  R. Gold,et al.  Fumaric acid and its esters: an emerging treatment for multiple sclerosis with antioxidative mechanism of action. , 2012, Clinical immunology.

[60]  A. IJzerman,et al.  Biological and pharmacological roles of HCA receptors. , 2011, Advances in pharmacology.

[61]  K. Takeda,et al.  ATF6β is a host cellular target of the Toxoplasma gondii virulence factor ROP18 , 2011, The Journal of Experimental Medicine.

[62]  S. Ghosh,et al.  Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. , 2001, The Journal of clinical investigation.

[63]  H. Pahl,et al.  Activators and target genes of Rel/NF-kappaB transcription factors. , 1999, Oncogene.